We use cookies to improve your experience. By continuing to browse this site, you accept our cookie policy.×
Skip main navigation
Aging Health
Bioelectronics in Medicine
Biomarkers in Medicine
Breast Cancer Management
CNS Oncology
Colorectal Cancer
Concussion
Epigenomics
Future Cardiology
Future Medicine AI
Future Microbiology
Future Neurology
Future Oncology
Future Rare Diseases
Future Virology
Hepatic Oncology
HIV Therapy
Immunotherapy
International Journal of Endocrine Oncology
International Journal of Hematologic Oncology
Journal of 3D Printing in Medicine
Lung Cancer Management
Melanoma Management
Nanomedicine
Neurodegenerative Disease Management
Pain Management
Pediatric Health
Personalized Medicine
Pharmacogenomics
Regenerative Medicine
Short CommunicationFree Access

The divergence between SARS-CoV-2 and RaTG13 might be overestimated due to the extensive RNA modification

    Yue Li

    Department of Respiratory Diseases, Qingdao Haici Hospital, PR China

    ,
    Xinai Yang

    Department of Respiratory Diseases, Qingdao Haici Hospital, PR China

    ,
    Na Wang

    Department of Respiratory Diseases, Qingdao Haici Hospital, PR China

    ,
    Haiyan Wang

    Department of Respiratory Diseases, Qingdao Haici Hospital, PR China

    ,
    Bin Yin

    Department of Respiratory Diseases, Qingdao Haici Hospital, PR China

    ,
    Xiaoping Yang

    Department of Respiratory Diseases, Qingdao Haici Hospital, PR China

    &
    Wenqing Jiang

    *Author for correspondence: Tel.: 86 0532 8377 7856;

    E-mail Address: qdhospit87@163.com

    Department of Respiratory Diseases, Qingdao Haici Hospital, PR China

    Published Online:https://doi.org/10.2217/fvl-2020-0066

    Abstract

    Aim: Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has spread throughout the world. There is urgent need to understand the phylogeny, divergence and origin of SARS-CoV-2. Materials & methods: A recent study claimed that there was 17% divergence between SARS-CoV-2 and RaTG13 (a SARS-related coronaviruses) on synonymous sites by using sequence alignment. We re-analyzed the sequences of the two coronaviruses with the same methodology. Results: We found that 87% of the synonymous substitutions between the two coronaviruses could be potentially explained by the RNA modification system in hosts, with 65% contributed by deamination on cytidines (C-T mismatches) and 22% contributed by deamination on adenosines (A-G mismatches). Conclusion: Our results demonstrate that the divergence between SARS-CoV-2 and RaTG13 has been overestimated.

    The spread of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) needs to be controlled [1–3], and meanwhile its outbreak provides an opportunity for evolutionary biologists to investigate the viruses from the angle of evolution. The ultimate ambition might be finding out the origin and evolving patterns of SARS-CoV-2.

    With or without much knowledge of virology, the evolutionary formula or algorithms could be easily applied to the virus sequences by using software or manual calculation. A previous study focusing on the origin and continuous evolution of SARS-CoV-2 (Tang et al. 2020 [4]) has an interesting finding that the synonymous substitution rate (dS) between SARS-CoV-2 and RaTG13 (one of the bat SARS-related coronaviruses) is 17%, which is 14-times the divergence between human and chimpanzee. This divergence as high as 17% is much greater than the estimation of earlier studies. The authors commented that the difference between SARS-CoV-2 and RaTG13 has been underestimated by earlier papers.

    The authors’ opinion is that only the silent mutations should be used to calculate the divergence between SARS-CoV-2 and RaTG13, because these neutral sites are not affected by selection forces. By using the formula dS = 2ut, where dS represents substitution rate and u is the mutation rate, one could estimate the divergent time (t) between the two species.

    Despite the terminology ‘mutation’ widely being used by evolutionary biologists, in many cases ‘mutation’ has been used in broad-sense, which represents all kinds of mismatches observed in the sequence alignment, no matter these mismatches are caused by natural mutation (such as replication errors) or other factors.

    The cellular organisms have multiple RNA modification systems, which could modify any types of RNAs in the cell. Since SARS-CoV-2 and RaTG13 are coronaviruses (RNA viruses), when they infect the human cell, the RNA modification enzymes might act on the viral RNAs as they usually do to the host RNAs. Modified viral RNAs such as the methylated adenosines have been commonly observed [5–7]. Apart from the minor decorations such as methylation, two major deamination enzymes, ADAR [8] and APOBEC [9,10], are responsible for adenosine-to-inosine deamination and cytidine-to-uracil deamination, leading to an observed A-to-G and C-to-T change in the sequencing results. No matter which of SARS-CoV-2 and RaTG13 is modified, it will produce an A-G or C-T mismatch in the alignment between two viruses. In mammals, ADAR is required to fight against the infected hepatitis C virus (HCV) [11–13]. Similar to coronavirus, the HCV is a positive-strand RNA virus, and the case of ADAR acting on HCV means that the deamination on viral RNAs (thus inducing mismatches against the reference sequence) is prevalent. In other invertebrate organisms, the mismatches induced from ADAR deamination is observed in sigma virus, a negative sense RNA virus [14–16]. Evidence shows that the ADAR-modified viral RNAs are not rapidly degraded so that the ‘offspring’ of the deaminated RNA would permanently carry this mutation [11].

    In the dS calculation, any observed mismatches in the sequence alignment are regarded as mutations. Of course, the software would not automatically tell the users whether a mismatch is a natural mutation caused by replication error or an RNA modification site.

    However, for DNA organisms like humans, the classic definition of mutation rate should mainly (perhaps not absolutely) refer to the replication error rate of DNA. For SARS-CoV-2, the mutation rate should mainly refer to the RNA replication error rate. Accordingly, the calculation of dS should only include the natural mutations introduced during RNA replication rather than the RNA-to-RNA mismatch sites caused by RNA modification system. The replication error rate should be very low while the occurrence of RNA modification could appear in any virus RNA which is exposed to the host's deamination enzymes. The RNA modification rate could be higher than RNA replication rate for orders of magnitude. The phenomenon that the viral RNAs or even proteins are modified by host cells is not rare at all [13,17] so that this issue should be considered when studying the divergence of RNA viruses.

    Our idea is that when checking the sequence alignment between SARS-CoV-2 and RaTG13, if one found that plenty of the synonymous substitutions could be potentially explained by C-to-T deamination or A-to-G deamination then the actual divergence between SARS-CoV-2 and RaTG13 might have been overestimated by many times. We re-emphasize that we only say the C-T and A-G mismatches could be potentially explained by RNA modification but not definitely caused by RNA modification. The aim is to rationally estimate the real divergence between the two RNA viruses.

    Materials & methods

    We downloaded the sequences of SARS-CoV-2 and RaTG13 from GeneBank and aligned the coding sequences with MUSCLE [13]. The 11 nonredundant ORFs are annotated with names (such as M, N, ORF1AB) so that we put the two ortholog genes into a file and run the sequence alignment. The length of each ORF (number of amino acids) and the aligned length of each ORF are given in Table 1. For example, we put the two sequences of SARS-CoV-2 ORF10 and RaTG13 ORF10 into one file and run MUSCLE with default parameter. Then the output file would give us the aligned sequences of these two ORFs. From Table 1, we could see that the ORFs in two virus species are almost of the same length so that the parameters hardly affect the alignment results. We manually extract each codon in the alignment file using our own python script. The unaligned regions are gaps. As shown in Table 1, only ORF1AB have two triplets (codons) unaligned, and the other regions and other ORFs are well aligned. Next, most of the aligned regions are identical. The nonidentical regions are either missense or synonymous mutations. To help readers understand the process of extracting mutations (mismatches) from the alignment, we listed the first ten missense and synonymous mutations of ORF1AB in Tables 2 & 3, respectively. From Tables 2 & 3, we already see prevalent C-T mismatches.

    Table 1. The length and aligned length of each ORF of SARS-CoV-2.
    ORF IDLength (amino acids)Aligned length in RaTG13
    E7575
    M222222
    N419419
    ORF103838
    ORF1AB70957093
    ORF3A275275
    ORF66161
    ORF7A121121
    ORF7B4343
    ORF8121121
    S12731273
    Table 2. The first ten missense mutations in ORF1AB.
    PositionSARS-CoV-2RaTG13Amino acid (SARS-CoV-2)Amino acid (RaTG13)Mismatch (nondirectional)
    38GTCGCTValAlaC-T
    110CATTATHisTyrC-T
    114ATAACAIleThrC-T
    117GCTGTTAlaValC-T
    172GAAGATGluAspA-T
    280ATAACAIleThrC-T
    376TCACCASerProC-T
    395ACCCCCThrProA-C
    417CATTACHisTyrC-T
    424GTTATTValIleA-G
    Table 3. The first ten synonymous mutations in ORF1AB.
    PositionSARS-CoV-2RaTG13Amino acid (SARS-CoV-2)Amino acid (RaTG13)Mismatch (nondirectional)
    20GTTGTCValValC-T
    59GGCGGTGlyGlyC-T
    74TCGTCTSerSerG-T
    82GGTGGCGlyGlyC-T
    92CTCCTTLeuLeuC-T
    97TACTATTyrTyrC-T
    104CTTCTCLeuLeuC-T
    138GCCGCTAlaAlaC-T
    142TCATCGSerSerA-G
    169GTTGTCValValC-T

    It is possible that sometimes the mutation may be lethal, producing shortened protein if TAA is produced instead of CAA. We scanned the 11 nonredundant ORFs in SARS-CoV-2 and RaTG13. We did not find any internal stop codons in these ORFs.

    For the multiple alignment incorporating other virus species ZXC21, ZC45 and BM48-31, we aligned the ORFs with the same method. Together with SARS-CoV-2 and RaTG13, we put the orthologous ORF of the five species into one file and run MUSCLE. The output alignment file was manually inspected. Each codon located in the ORFs were simply extracted by our own python scripts. The results of aligning SARS-CoV-2 and RaTG13 and the results calculated from aligning five species were compared. The relative alignment and mismatch profiles between SARS-CoV-2 and RaTG13 were found to be identical under two sets of strategies.

    The ID of SARS-CoV-2 is NC_045512. The link of SARS-CoV-2 ORF1AB (coding sequence) is: https://www.ncbi.nlm.nih.gov/nuccore/NC_045512.2?from=266&to=21555&report=fasta

    The ID of RaTG13 is MN996532. The link of RaTG13 genome is: https://www.ncbi.nlm.nih.gov/nuccore/MN996532.1/?report=fasta

    The beginning of SARS-CoV-2 ORF1AB is ‘ATG|GAG|AGC|CTT|GTC’, the end of SARS-CoV-2 ORF1AB is ‘GAT|GTT|CTT|GTT|AAC|AAC|TAA’. By manually searching ‘ATGGAGAGCCTTGTC’ and ‘GATGTTCTTGTTAACAACTAA’ in the RaTG13 genome sequence, we can anchor and extract the ORF1AB in the RaTG13 genome. The ORF1AB CDS alignment between SARS-CoV-2 and RaTG13 is provided in Supplementary Table 1. As we can see, most codons are identical. The nonidentical codons mostly have synonymous mutations.

    Results

    Substitutions between SARS-CoV-2 & RaTG13

    We aligned the ORFs of SARS-CoV-2 and RaTG13 and manually extracted the codons in the alignment file (see Materials and methods). The statistics of the alignment results (Table 1) show that most of the ORFs are well aligned and only ORF1AB has two gaps. From the 9.7 thousand codons in the ORFs, we totally obtained 1076 nonidentical codon positions between SARS-CoV-2 and RaTG13, 931 of which encode the same amino acid (synonymous) and 145 of which encode different amino acids (missense). That is to say, there are 931 synonymous substitutions and 145 missense substitutions between SARS-CoV-2 and RaTG13. The other ORF regions (90%) are identical between SARS-CoV-2 and RaTG13.

    Among the 9.7 thousand codons in the 11 nonredundant SARS-CoV-2 ORFs, the content of C and T is 51.2%. However, among the 931 codons with synonymous substitutions, the content of C and T is 56.1%, and the difference is significant using Chi-square test (p = 5.7E-3). It proves that the occurrence of synonymous substitutions is nonrandom and it tends to take place on codons containing C or T.

    87% of the synonymous substitutions are C-T or A-G mismatches

    We checked the 1076 substitution sites between SARS-CoV-2 and RaTG13, 84.4% of the mutations are A-G or C-T mismatches (61.0% C-T mismatches and 23.4% A-G mismatches). Among the 931 synonymous substitution sites (Figure 1), 86.7% of them are A-G or C-T mismatches (64.9% C-T mismatches and 21.8% A-G mismatches). This mismatch spectrum resembles the enrichment of C-to-T(U) deamination and A-to-G(I) deamination. Nearly 87% of the observed synonymous ‘mutations’ between SARS-CoV-2 and RaTG13 could be potentially explained by the RNA modification systems in host cells.

    Figure 1. The numbers of mismatch types on synonymous substitution sites between SARS-CoV-2 and RaTG13.

    To help readers understand how the mismatches were extracted from the alignment file, we listed the first ten missense and synonymous mutations in ORF1AB, respectively (Tables 2 & 3). We have said that 90% of the aligned regions is identical and the nonidentical codons usually differ with a single nucleotide. In Table 2, seven out of the ten missense substitutions were C-T mismatches. In Table 3, eight out of the ten synonymous substitutions were C-T mismatches. Given the high similarity of the SARS-CoV-2 and RaTG13 sequences, these mismatches may not be caused by mis-alignment.

    One may also be concerned whether the alignment and mismatch profile is different when using multiple virus species to run the alignment. We downloaded the ORFs of other SARS-related coronaviruses ZXC21, ZC45, and BM48-31 (see Materials and methods). We found that using multiple species does not affect the aligned regions between SARS-CoV-2 and RaTG13. Although additional gaps are introduced in the alignment, the relative position between SARS-CoV-2 and RaTG13 remains the same. So, the mismatches between SARS-CoV-2 and RaTG13 are not affected by different alignment strategies. The prevalence of C-T and A-G mismatches is robust.

    Mismatch profile excluding the protease digestion sites in ORF1AB

    The ORF1AB (pp1AB) would be cleaved into multiple proteins (nsp1-16) by protease. The cleavage sites are LQS and LQA sequences [18,19]. We could not simply call ORF1AB as one gene, so it is rational to exclude the mutations in digestion sites in the divergence analyses. We checked the mutations in the LQS and LQA regions. We only found one case. Amino acids 4252-4254 is Leu-Gln-Ala, and the Leu codon is CTA in SARS-CoV-2 and TTA in RaTG13. This single C-T mismatch in digestion regions does not affect the overall mismatch profile. This also proves that the amino acid sequences of digestion sites might be highly conserved to avoid the loss of protease recognition. Again, our finding of prevalent C-T and A-G mismatches is robust.

    ORF1AB & S contribute most of the mismatches

    It is necessary to provide the influence of the tested number of genes on the estimated divergence. As seen in Table 1, ORF1AB and S are the longest ORFs. They contribute most of the mismatches if we look at the mismatch profile in all the ORFs. Here we list the dS values calculated by Tang et al. [4] and the percent of mismatches potentially explained by RNA modification (Table 4). ORF1AB, S, and the other ORFs are listed separately. Clearly, the choice of tested genes does not severely affect the pattern. In all genes, 87% mutations could be (potentially) explained by modified RNA. In ORF1AB, 89% mutations could be (potentially) explained by RNA modification. In S, 78% mutations could be (potentially) explained by modified RNA. In the remaining ORFs, 91% mutations could be (potentially) explained by modified RNA. Presume that 91% of the mismatches are caused by RNA modification, then the dS value is overestimated for more than tenfolds. The S ORF has a pretty high dS value, so it is especially necessary to question if the modification system contributes to the divergence.

    Table 4. dS values and the fold of overestimation.
    ORFdS (Tang et al.)C-T mismatchA-G mismatchExplained by modification (upper bound)Fold of overestimation of dS (upper bound)
    All0.1765%22%87%7.7
    ORF1AB0.15267%22%89%9.2
    S0.32159%19%78%4.5
    OtherNot provided64%27%91%10.9

    Discussion

    One argument is that in the alignment between SARS-CoV-2 and RaTG13 we did not use an outgroup species so that the direction of the mutation is uncertain. Yes, that is true. We do not worry about the ancestral state. SARS-CoV-2 and RaTG13 are RNA viruses. As long as we observe a C-T or A-G mismatch in the sequence alignment between them, we could speculate that the C-to-T or A-to-G deamination might have occurred in one of the two virus species.

    Note that we only say 87% of the mutations could be potentially explained by RNA modification, rather than 87% of them are definitely caused by RNA modification. From the sequence alignment alone, it is impossible to know whether the mismatch is a ‘de novo’ mutation or an RNA modification site. The software would not tell users what has caused this mismatch since it is technically indistinguishable. Improving the parameters only makes alignment more accurate but does not tell us the origin of the mismatch.

    As understood by common researchers, the definition of dS between RNA viruses mainly (but not absolutely) refers to the natural mutations introduced by RNA replication error rather than the RNA modification sites caused by host cells. The RNA modification rate is many times higher than the replication error rate. This fact is consistent with our notion that the divergence between RNA viruses is overestimated.

    According to our results, potentially 87% of the synonymous substitutions between SARS-CoV-2 and RaTG13 could be caused by RNA modification system in hosts. The remaining 13% of the substitutions should be genuine interspecific mutations as they could not be explained by known RNA modification types. The claimed dS = 0.17 should have been overestimated. The upper bound of overestimation is 1/0.13 = 7.7-times so that the lower bound of the dS value is 0.17/7.7 = 0.022.

    Indeed, if the authors argue that the definition of dS itself already included any mutation types such as those RNA modification sites then the dS value of 17% would be valid. However, this definition of dS is not what we commonly understand, and the authors should have pointed this out in their article. Again, adjusting the parameters of any software only makes the alignment more accurate but is not helpful in determining whether the observed mismatches are modified RNA or the natural mutation introduced during RNA replication. A rational way to avoid a wrong and misleading conclusion is to calculate the upper bound and lower bound of the divergence value. Anyway, the currently proposed divergence (dS = 17%) between SARS-CoV-2 and RaTG13 has been severely overestimated. We appeal that when calculating dN and dS between RNA viruses, the RNA modification should be taken into account.

    The limitation of our study is that we were currently unable to provide experimental evidence for the modification on viral RNAs although this phenomenon is not new for virologists. At the same time, neither did Tang et al. [4] provide evidence to prove that the mismatches in the alignment are not caused by RNA modification. Since both sides lack experimental evidence, it is reasonable to think about this dilemma from the angle of maximum likelihood. That is, if the mismatch sites between SARS-CoV-2 and RaTG13 are really introduced by accumulation of RNA replication errors, they should not exhibit an excessive number of C-T and A-G mismatches (in that case the mutation types should be random).

    Another limitation of our work is that we did not give an estimation of the real divergence value. As we have stated, the RNA modifications and normal mutation sites are technically indistinguishable. We only say that the proposed 17% divergence is higher than the real value but we still do not know what the real value is. Promisingly, experts in mutations could estimate the relative abundance of each type of mismatches and give a reasonable value of the divergence between SARS-CoV-2 and RaTG13.

    Conclusion

    Since we found 87% of the synonymous substitution sites between SARS-CoV-2 and RaTG13 could be potentially explained by RNA modification system in host cells, we are strongly concerned that the previously defined divergence between SARS-CoV-2 and RaTG13 has been overestimated.

    Summary points
    • The outbreak of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has caused severe damage to the world.

    • It is necessary to understand the origin and evolution patterns of SARS-CoV-2.

    • A previous study claimed that SARS-CoV-2 and RaTG13 have 17% divergence on synonymous sites.

    • We aligned the coding sequences of SARS-CoV-2 and RaTG13, and checked the substitution sites between them.

    • The substitution sites are CT-enriched compared with background.

    • Potentially 87% of the synonymous substitutions between SARS-CoV-2 and RaTG13 could be explained by RNA modification system in hosts.

    • The divergence between SARS-CoV-2 and RaTG13 has been overestimated.

    • The calculation of dN or dS between RNA viruses should take the RNA modification into consideration.

    Supplementary data

    To view the supplementary data that accompany this paper please visit the journal website at: www.futuremedicine.com/doi/suppl/10.2217/fvl-2020-0066

    Author contributions

    The corresponding author designed and supervised this research. All authors contributed to writing this article.

    Acknowledgments

    The thank all the medical workers including ourselves for their hard work to fight against SARS-CoV-2. The thank the members in our group who have given suggestions to this article.

    Financial & competing interests disclosure

    The authors have no relevant affiliations or financial involvement with any organization or entity with a financial interest in or financial conflict with the subject matter or materials discussed in the manuscript. This includes employment, consultancies, honoraria, stock ownership or options, expert testimony, grants or patents received or pending, or royalties.

    No writing assistance was utilized in the production of this manuscript.

    References

    • 1. Wang C, Horby PW, Hayden FG, Gao GF. A novel coronavirus outbreak of global health concern. Lancet 395(10223), 470–473 (2020).
    • 2. Edelstein M, Heymann DL. What needs to be done to control the spread of Middle East respiratory syndrome coronavirus? Future Virol. 10(5), 497–505 (2015).
    • 3. Sheahan TP, Baric RS. Is regulation preventing the development of therapeutics that may prevent future coronavirus pandemics? Future Virol. 13(3), 143–146 (2018).
    • 4. Tang X, Wu C, Li X et al. On the origin and continuing evolution of SARS-CoV-2. National Science Review nwaa036 (2020). https://doi.org/10.1093/nsr/nwaa036
    • 5. Benvenuto D, Giovanetti M, Ciccozzi A, Spoto S, Angeletti S, Ciccozzi M. The 2019-new coronavirus epidemic: evidence for virus evolution. J. Med. Virol. doi:10.1002/jmv.25688 (2020).
    • 6. Xiao K, Zhai J, Feng Y et al. Isolation and characterization of 2019-nCoV-like coronavirus from Malayan pangolins. bioRxiv doi:10.1101/2020.02.17.951335 2020.2002.2017.951335 (2020).
    • 7. Lam TT-Y, Shum MH-H, Zhu H-C et al. Identification of 2019-nCoV related coronaviruses in Malayan pangolins in southern China. bioRxiv doi:10.1101/2020.02.13.945485 2020.2002.2013.945485 (2020).
    • 8. Zhao Z, Li H, Wu X et al. Moderate mutation rate in the SARS coronavirus genome and its implications. BMC Evol. Biol. 4, 21 (2004).
    • 9. Gonzales-Van Horn SR, Sarnow P. Making the mark: the role of adenosine modifications in the life cycle of RNA viruses. Cell Host Microbe 21(6), 661–669 (2017).
    • 10. Viehweger A, Krautwurst S, Lamkiewicz K et al. Direct RNA nanopore sequencing of full-length coronavirus genomes provides novel insights into structural variants and enables modification analysis. Genome Res. 29(9), 1545–1554 (2019).
    • 11. Taylor DR, Puig M, Darnell MER, Mihalik K, Feinstone SM. New antiviral pathway that mediates hepatitis C virus replicon interferon sensitivity through ADAR1. J. Virol. 79(10), 6291–6298 (2005).
    • 12. Zahn RC, Schelp I, Utermohlen O, Von Laer D. A-to-G hypermutation in the genome of lymphocytic choriomeningitis virus. J. Virol. 81(2), 457–464 (2007).
    • 13. Carpenter JA, Keegan LP, Wilfert L, O'connell MA, Jiggins FM. Evidence for ADAR-induced hypermutation of the Drosophila sigma virus (Rhabdoviridae). BMC Genet. 10, 75 (2009).
    • 14. Mahieux R, Suspene R, Delebecque F et al. Extensive editing of a small fraction of human T-cell leukemia virus type 1 genomes by four APOBEC3 cytidine deaminases. J. Gen. Virol. 86(Pt 9), 2489–2494 (2005).
    • 15. Suspene R, Aynaud MM, Koch S et al. Genetic editing of herpes simplex virus 1 and Epstein-Barr herpes virus genomes by human APOBEC3 cytidine deaminases in culture and in vivo. J. Virol. 85(15), 7594–7602 (2011).
    • 16. Peretti A, Geoghegan EM, Pastrana DV et al. Characterization of BK polyomaviruses from kidney transplant recipients suggests a role for APOBEC3 in driving in-host virus evolution. Cell Host Microbe 23(5), 628–635; e627 (2018).
    • 17. Fung TS, Liu DX. Post-translational modifications of coronavirus proteins: roles and function. Future Virol. 13(6), 405–430 (2018).
    • 18. Krichel B, Falke S, Hilgenfeld R, Redecke L, Uetrecht C. Processing of the SARS-CoV pp1a/ab nsp7-10 region. Biochem. J. 477(5), 1009–1019 (2020).
    • 19. Ziebuhr J, Siddell SG. Processing of the human coronavirus 229E replicase polyproteins by the virus-encoded 3C-like proteinase: identification of proteolytic products and cleavage sites common to pp1a and pp1ab. J. Virol. 73(1), 177–185 (1999).